Drug Shortage Report for LUPIN-CEPHALEXIN

Last updated on 2020-10-06 History
Report ID 104566
Drug Identification Number 02469189
Brand name LUPIN-CEPHALEXIN
Common or Proper name LUPIN-CEPHALEXIN
Company Name LUPIN PHARMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEPHALEXIN
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 100 ML and 150 ML
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-28
Estimated end date 2020-10-09
Actual end date 2020-10-05
Shortage status Resolved
Updated date 2020-10-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 550-1111 RUE ST-CHARLES OUEST
LONGUEUIL, QUEBEC
CANADA J4K 5G4
Company contact information lupin@lsu3pl.ca (Customer service / Service à la clientèle)

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-28 English Compare
v2 2020-01-28 French Compare
v3 2020-01-28 French Compare
v4 2020-01-29 English Compare
v5 2020-07-07 English Compare
v6 2020-07-07 French Compare
v7 2020-08-27 English Compare
v8 2020-08-27 French Compare
v9 2020-09-30 English Compare
v10 2020-09-30 French Compare
v11 2020-10-05 English Compare
v12 2020-10-05 French Compare
v13 2020-10-06 English Compare

Showing 1 to 13 of 13